X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
index medicus (24) 24
female (19) 19
male (19) 19
aged (13) 13
middle aged (13) 13
respiratory system (13) 13
copd (12) 12
lung diseases, obstructive (12) 12
obstructive pulmonary-disease (12) 12
chronic obstructive pulmonary disease (11) 11
analysis (10) 10
pulmonary disease, chronic obstructive - diagnosis (9) 9
studies (9) 9
therapy (9) 9
treatment outcome (9) 9
cost-benefit analysis (8) 8
drug therapy (8) 8
pulmonary disease, chronic obstructive - drug therapy (8) 8
safety (8) 8
united kingdom (8) 8
costs (7) 7
economics (7) 7
health care costs (7) 7
international journal of chronic obstructive pulmonary disease (7) 7
pulmonary disease, chronic obstructive - physiopathology (7) 7
care and treatment (6) 6
double-blind (6) 6
guidelines (6) 6
health policy & services (6) 6
patients (6) 6
prevalence (6) 6
research (6) 6
time factors (6) 6
tiotropium (6) 6
adherence (5) 5
antibodies, monoclonal - economics (5) 5
bronchodilator agents - therapeutic use (5) 5
disease progression (5) 5
diseases of the respiratory system (5) 5
efficacy (5) 5
health care (5) 5
infliximab (5) 5
internal medicine (5) 5
medical care, cost of (5) 5
medicine & public health (5) 5
original research (5) 5
public health (5) 5
pulmonary disease, chronic obstructive - economics (5) 5
quality-adjusted life years (5) 5
resource use (5) 5
respiratory tract diseases (5) 5
retrospective studies (5) 5
systematic review (5) 5
abstracts (4) 4
administration, inhalation (4) 4
adrenergic beta-2 receptor agonists - therapeutic use (4) 4
asthma (4) 4
clinical trials (4) 4
cost-effectiveness (4) 4
cross-sectional studies (4) 4
drugs (4) 4
dyspnea (4) 4
epidemiology (4) 4
health care sciences & services (4) 4
hiv (4) 4
lung - physiopathology (4) 4
management (4) 4
meta-analysis (4) 4
primary care (4) 4
primary health care (4) 4
pulmonary disease, chronic obstructive - epidemiology (4) 4
quality-of-life (4) 4
severity of illness index (4) 4
united kingdom - epidemiology (4) 4
usage (4) 4
adrenal cortex hormones - therapeutic use (3) 3
anti-inflammatory agents - economics (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antiretroviral agents (3) 3
antiretroviral drugs (3) 3
antiretroviral therapy (3) 3
barriers (3) 3
bronchodilator agents - administration & dosage (3) 3
child (3) 3
comparative analysis (3) 3
cost effectiveness (3) 3
cost of illness (3) 3
data collection (3) 3
databases, factual (3) 3
development and progression (3) 3
disability (3) 3
disease (3) 3
dolutegravir (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
economic aspects (3) 3
exacerbations (3) 3
follow-up studies (3) 3
forced expiratory volume (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
AIDS, ISSN 0269-9370, 09/2019, Volume 33, Issue 11, pp. 1739 - 1749
OBJECTIVE:Compare the efficacy and safety of the 2-drug antiretroviral therapy regimen dolutegravir + lamivudine (DTG + 3TC) with traditional 3-drug regimens... 
Lamivudine | Usage | Drug therapy | Comparative analysis | HIV infection | Patient outcomes | Clinical Science | antiretroviral agents | HIV | combination drug therapy | dolutegravir | network meta-analysis | lamivudine
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Respiratory Research, ISSN 1465-9921, 11/2015, Volume 16, Issue 1, p. 141
Background: To assess the symptomatic and cost burden among patients initiating long-acting bronchodilator (LABD) therapy and impact of adherence on healthcare... 
Costs | Long-acting bronchodilators | Primary care | Retrospective cohort study | COPD | Resource use | GUIDELINES | BARRIERS | ADHERENCE | HOSPITALIZATION | OBSTRUCTIVE PULMONARY-DISEASE | THERAPY | RESPIRATORY SYSTEM | DRUGS | Bronchodilator Agents - therapeutic use | Drug Costs | Glucocorticoids - therapeutic use | Muscarinic Antagonists - economics | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Muscarinic Antagonists - therapeutic use | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Glucocorticoids - economics | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Retrospective Studies | General Practice - economics | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Pulmonary Disease, Chronic Obstructive - economics | Databases, Factual | Bronchodilator Agents - economics | Pulmonary Disease, Chronic Obstructive - diagnosis | Health Resources - economics | Treatment Outcome | United Kingdom | Lung - physiopathology | Disease Progression | Medication Adherence | Adrenergic beta-2 Receptor Agonists - economics | Cost-Benefit Analysis | Lung - drug effects | Office Visits - economics | Aged | Primary Health Care - economics | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Care and treatment | Analysis | Research | Health aspects | Bronchodilator agents | Medical care, Cost of
Journal Article
Respiratory Research, ISSN 1465-9921, 05/2017, Volume 18, Issue 1, pp. 86 - 9
Journal Article
International Journal of COPD, ISSN 1176-9106, 11/2015, Volume 10, Issue 1, pp. 2495 - 2517
Background: Randomized, controlled trials comparing long-acting muscarinic antagonist (LAMA) efficacy in COPD are limited. This network meta-analysis (NMA)... 
Anticholinergics | Systematic review | Muscarinic antagonist | Bronchodilator | Meta-analysis | PLACEBO | SAFETY | DAILY ACLIDINIUM BROMIDE | meta-analysis | systematic review | SALMETEROL | ONCE-DAILY TIOTROPIUM | TRIAL | OBSTRUCTIVE PULMONARY-DISEASE | muscarinic antagonist | RESPIRATORY SYSTEM | EXACERBATIONS | GLYCOPYRRONIUM | anticholinergics | bronchodilator | Spirometry | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Quinuclidines - administration & dosage | Recovery of Function | Forced Expiratory Volume | Tiotropium Bromide - administration & dosage | Time Factors | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Pulmonary Disease, Chronic Obstructive - diagnosis | Drug Administration Schedule | Treatment Outcome | Lung - physiopathology | Randomized Controlled Trials as Topic | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Bayes Theorem | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Muscarinic antagonists | Tiotropium | Lung diseases, Obstructive | Care and treatment | Usage | Safety and security measures | Clinical trials | Dosage and administration
Journal Article
Journal Article
AIDS (London, England), 06/2019
Compare the efficacy and safety of the 2-drug antiretroviral therapy (ART) regimen dolutegravir + lamivudine (DTG+3TC) with traditional 3-drug regimens in... 
Journal Article
Cost Effectiveness and Resource Allocation, ISSN 1478-7547, 12/2019, Volume 17, Issue 1
Journal Article